Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2008; 29(02): 4-5
DOI: 10.4103/0971-5851.51424
Editorial

Ovarian cancer and haemostatic defect

Renu Saxena
Department of Hematology, All India Institute of Medical Sciences, New Delhi-110029, India
,
R Bhargav
Department of Hematology, All India Institute of Medical Sciences, New Delhi-110029, India
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints


Publication History

Article published online:
02 March 2022

© 2008. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Dong Y, Kaushal A, Brattsand M, Nicklin J, Clements JA: Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers. Clin Cancer Res 2003; 9:1710-1720.
  • 2 Sitalakshmi.S, Rameshkumar K and Damodar P. Significance of haemostatic markers in ovarian carcinoma. Ind J Med& Paed Oncol 2008; 29(2): 6-10.